Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.
AQST
$4.61
+0.88%
AQST
· Aquestive Therapeutics, Inc.
$4.61
+0.04 (+0.88%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$584.88M
Shares
125.51M
Volume · Oct 6
1.21M
Avg daily vol (3M)
2.64M
All webcasts
Earnings call · FY2026 Q2
Aquestive Therapeutics, Inc. (AQST) Q2 2026 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Revenue
$13.82M
+38.1% YoY
Diluted EPS
-$0.18
Net income
-$22.86M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 11, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Total revenues
2026 Outlook
|
$46M – $50M | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 11, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 11, 2026 · complete as-filed document